Hyun Seok Cho, Geun Tae Park, Young Hoon Kim, Sung Gon Shim, Jin Bae Kim, Oh Young Lee, Ho Soon Choi, Joon Soo Hahm, Min Ho Lee
{"title":"[The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].","authors":"Hyun Seok Cho, Geun Tae Park, Young Hoon Kim, Sung Gon Shim, Jin Bae Kim, Oh Young Lee, Ho Soon Choi, Joon Soo Hahm, Min Ho Lee","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aims: </strong>The diagnosis of refractory ascites means a poor prognosis for patients with liver cirrhosis. The definition of refractory ascites has already been established, but using the dosage of diuretics that correlates with the definition of refractory ascites in an out-patient department will lower the compliance of the patient, as well as causing serious complications, such as hepatic encephalopathy and hyponatremia, as the dosage of diuretics is increased. Due to this fact, it is very difficult to apply this definition of refractory ascites to patients in a domestic out-patient department. In this study, in situations where there are difficulties in applying the diuretics dosage according to definition of refractory ascites, we tried to find out whether measuring the value of urine sodium after the administration of intravenous furosemide can be the standard in early differentiation of the response to diuretics treatment.</p><p><strong>Methods: </strong>We reviewed 16 cases of liver cirrhosis with ascites and classified them into two groups by the response to diuretics. The diuretics-responsive ascites group was 8 cases and the diuretics-unresponsive ascites group consisted of 8 cases. After admission, we examined the patients' CBC, biochemical liver function test, spot urine sodium, and 24 hour creatinine clearance. After the beginning of the experiment, all diuretic therapy was stopped for 3 days. Daily we examined the patients' CBC, biochemical liver function test, and in the 3rd experiment day, we measured 24-hour urine volume and sodium. In the 4th experiment day, after sampling for ADH, plasma renin activity and plasma aldosterone level, we administrated the furosemide 80 mg I.V, and measured the amount of 8 hour urine volume and sodium.</p><p><strong>Results: </strong>The plasma aldosterone level was significantly higher in the diuretics- unresponsive ascites group than in the diuretics-responsive ascites group. In the 4th experiment day, the amount of urine volume and sodium was very significantly lower in the diuretics-unresponsive ascites group than in the diuretics-responsive ascites group (1297.5 +/-80.9 vs 2003.7 +/-114.6 ml, p<0.005, 77.3 +/-8.2 vs 211.8 +/-12.6 mEq, p<0.001).</p><p><strong>Conclusions: </strong>In out-patient departments, the measurement of urine sodium 8 hours after administrating 80 mg of intravenous furosemide, will help in differentiating ascites patients with lower treatment response to diuretics.</p>","PeriodicalId":85610,"journal":{"name":"Taehan Kan Hakhoe chi = The Korean journal of hepatology","volume":"9 4","pages":"324-31"},"PeriodicalIF":0.0000,"publicationDate":"2003-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Taehan Kan Hakhoe chi = The Korean journal of hepatology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background/aims: The diagnosis of refractory ascites means a poor prognosis for patients with liver cirrhosis. The definition of refractory ascites has already been established, but using the dosage of diuretics that correlates with the definition of refractory ascites in an out-patient department will lower the compliance of the patient, as well as causing serious complications, such as hepatic encephalopathy and hyponatremia, as the dosage of diuretics is increased. Due to this fact, it is very difficult to apply this definition of refractory ascites to patients in a domestic out-patient department. In this study, in situations where there are difficulties in applying the diuretics dosage according to definition of refractory ascites, we tried to find out whether measuring the value of urine sodium after the administration of intravenous furosemide can be the standard in early differentiation of the response to diuretics treatment.
Methods: We reviewed 16 cases of liver cirrhosis with ascites and classified them into two groups by the response to diuretics. The diuretics-responsive ascites group was 8 cases and the diuretics-unresponsive ascites group consisted of 8 cases. After admission, we examined the patients' CBC, biochemical liver function test, spot urine sodium, and 24 hour creatinine clearance. After the beginning of the experiment, all diuretic therapy was stopped for 3 days. Daily we examined the patients' CBC, biochemical liver function test, and in the 3rd experiment day, we measured 24-hour urine volume and sodium. In the 4th experiment day, after sampling for ADH, plasma renin activity and plasma aldosterone level, we administrated the furosemide 80 mg I.V, and measured the amount of 8 hour urine volume and sodium.
Results: The plasma aldosterone level was significantly higher in the diuretics- unresponsive ascites group than in the diuretics-responsive ascites group. In the 4th experiment day, the amount of urine volume and sodium was very significantly lower in the diuretics-unresponsive ascites group than in the diuretics-responsive ascites group (1297.5 +/-80.9 vs 2003.7 +/-114.6 ml, p<0.005, 77.3 +/-8.2 vs 211.8 +/-12.6 mEq, p<0.001).
Conclusions: In out-patient departments, the measurement of urine sodium 8 hours after administrating 80 mg of intravenous furosemide, will help in differentiating ascites patients with lower treatment response to diuretics.
背景/目的:难治性腹水的诊断意味着肝硬化患者预后不良。难治性腹水的定义已经确立,但在门诊使用与难治性腹水定义相关的利尿剂剂量,不仅会降低患者的依从性,而且随着利尿剂剂量的增加,还会引起肝性脑病、低钠血症等严重并发症。因此,很难将难治性腹水的定义应用于国内门诊患者。在本研究中,在根据难治性腹水的定义难以确定利尿剂用量的情况下,我们试图探讨静脉滴注速尿后测定尿钠值是否可以作为早期鉴别利尿剂治疗反应的标准。方法:回顾性分析16例肝硬化腹水患者,按利尿剂疗效分为两组。利尿剂反应性腹水组8例,利尿剂无反应性腹水组8例。入院后,我们检查了患者的CBC、生化肝功能、尿钠斑点、24小时肌酐清除率。实验开始后,停用所有利尿剂治疗3天。每天检查患者CBC、生化肝功能,实验第3天测定24小时尿量和钠含量。实验第4天,采集ADH、血浆肾素活性、血浆醛固酮水平后,静脉滴注速尿80 mg,测定8小时尿量和钠量。结果:利尿剂无反应腹水组血浆醛固酮水平明显高于利尿剂有反应腹水组。实验第4天,利尿剂无反应腹水组尿量和尿钠量明显低于利尿剂有反应腹水组(1297.5 +/-80.9 ml vs 2003.7 +/-114.6 ml)。结论:在门诊,静脉滴注速尿80 mg后8 h测尿钠量,有助于鉴别利尿剂治疗反应较低的腹水患者。